跳至主要内容
临床试验/NCT03628456
NCT03628456已完成不适用

Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements, Comparative Study

International Biophysics Corporation2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2018年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
2
主要终点
Peak Expiratory Flow (PEF) Assessed in Participants at Baseline and With Both Devices

研究概览

简要总结

The impact of high-frequency chest wall oscillation therapy on spirometry values (Forced Expiratory Volume, Forced Vital Capacity, Peak Expiratory Flow, Forced Expiratory Flow and Tidal Volume is investigated during use of several products and comparing to baseline values

详细描述

The study will be broken into one (1) arm:

• AffloVest® & Monarch™

Within the arm, the order of products will be randomized.

Baseline spirometry (Forced Expiratory Volume (FEV1), Forced Vital Capacity (FVC), Peak Expiratory Flow (PEF), Forced Expiratory Flow (FEF25-75%) and Tidal Volume (TV)) will be taken at the beginning, middle and end of each series of measurements with each subject, without any device on the subject. A product (AffloVest or Monarch) will be placed onto subject and turned ON to the highest frequency and intensity settings. Then the subject will be given a certain period of time to adjust and spirometry measurements will then be repeated, then the product will be removed and the subject will be allowed a recovery period, then the other product will be placed on the subject, turned ON and spirometry measurements will repeated.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy subject, ages 18 - 50

排除标准

  • Non-ambulatory
  • diagnosed neuromuscular disorder
  • currently using any type of oscillation vest therapy
  • diagnosed co-morbid condition (i.e. lung cancer, other lung disorder or disease)
  • currently enrolled in a medical research study
  • non-English speaking
  • presence of the following active implantable devices: pacemakers, neurostimulators, infusion pumps, circulatory support devices, implantable cardioverter defibrillators (ICD's), cochlear implants
  • presence of head and/or neck injury that has not yet been stabilized
  • presence of active hemorrhage with hemodynamic instability

结局指标

主要结局

Peak Expiratory Flow (PEF) Assessed in Participants at Baseline and With Both Devices

时间窗: 30 minutes

Peak Expiratory Flow (PEF) measures the peak flow during a forced exhalation, measured using standard spirometry techniques

Forced Expiratory Volume (1 Second) Assessed in Participants at Baseline and With Both Devices

时间窗: 30 minutes

Forced Expiratory Volume in 1 second (FEV1) measures how much air a person can exhale during a forced breath during the first one (1) second, measured using standard spirometry techniques

Forced Vital Capacity (FVC) Assessed in Participants at Baseline and With Both Devices

时间窗: 30 minutes

Forced Vital Capacity (FVC) is the total amount of air exhaled during the FEV test, measured using standard spirometry techniques

Tidal Volume (TV) Assessed in Participants at Baseline and With Both Devices

时间窗: 30 minutes

Tidal Volume is the normal volume of air displaced between normal inhalation and exhalation, measured using standard sprirometry techniques

Forced Expiratory Flow (FEF25-75%) Assessed in Participants at Baseline and With Both Devices

时间窗: 30 minutes

Forced Expiratory Flow (25-75%) is the average flow from the point at which 25% of the FVC has been exhaled to the point at which 75% of the FVC has been exhaled, measured using standard spirometry techniques

次要结局

未报告次要终点

研究者

发起方
International Biophysics Corporation
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Effect of HFCWO Vests on Spirometry Measurements | 临床试验